Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Best and Worst from Shareholder Meeting

As for the BEST:

There are 2 reports I've noted that indicate that it was mentioned that either $350M or $345M has been earned by the MMP during the licensing program begain. Considering that through the quarter that we just got the 10q on last month, it had previously been reported that MMP earnings totaled $308M, that means that THE CURRENT QUARTER WE'RE IN WILL REFLECT MMP EARNINGS TO PDS OF AT LEAST $38M and maybe as high at $42M, NOT INCLUDING any additional signings they might secure before the end of the month!

If Leckrone is telling the truth (and he better be considering he's at the PTSC ASM, and while not a part of the company technically, he is REPRESENTING PTSC in those comments and would expose PTSC to severe liability issues if what he said was false), this will represent the THIRD BEST MMP REVENUE GENERATING QUARTER IN HISTORY!

IMO, that's a very significant development.

I agree 100%--Wonder if the Tyco figures were in that # as it had just happened the day before.

Up, Up, and to the Right!! GL, ads

Share
New Message
Please login to post a reply